Oliver Bechter

Also affiliated with KU Leuven

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity”.

The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity

Cancer Cell(2023)10.1016/j.ccell.2023.05.014

N/A

1.8DataRank · unranked

96 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Joanna Poźniak, Shivem B. Shah +28 more

Multiplexed Immunohistochemistry and Digital Pathology as the Foundation for Next-Generation Pathology in Melanoma: Methodological Comparison and Future Clinical Applications

Frontiers in Oncology(2021)10.3389/fonc.2021.636681

N/A

1.8DataRank · unranked

39 citations

Asier Antoranz, Madhavi Dipak Andhari, Giorgia Milli, Oliver Bechter, Frederik De Smet +2 more

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study

Clinical and Translational Science(2024)10.1111/cts.13854

N/A

0.360DataRank · unranked

10 citations

Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve +16 more

A neural crest stem cell-like state drives nongenetic resistance to targeted therapy in melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.15.422929

N/A

0DataRank · unranked

7 citations

Aljosja Rogiers, Michael Dewaele, Julia Femel, Panagiotis Karras, Joanna Poźniak +19 more

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Cancer Cell(2021)10.1016/j.ccell.2021.05.015

N/A

0DataRank · unranked

154 citations

Aljosja Rogiers, Michael Dewaele, Julia Femel, Panagiotis Karras, Joanna Poźniak +20 more

Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients

European Journal of Cancer(2024)10.1016/j.ejca.2024.115119

N/A

0DataRank · unranked

14 citations

G.V. Long, John O. Larkin, Jedd D. Wolchok, J.C. Hassel, D. Schadendorf +16 more